Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01293552 · ClinicalTrials.gov registry record · Phase 2
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
A Phase 2 study, sponsored by Anterios.
- Completed
- Registry status
- Phase 2
- Development phase
- 72
- Enrollment target
NCT01293552: Completed Phase 2 study, sponsored by Anterios.
NCT01293552 is a Phase 2 study that has completed, run by Anterios. The registered enrollment target is 72 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (46% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01293552, a Phase 2 study, has completed, sponsored by Anterios.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of ANT-1207 in the treatment of acne.
Primary Outcome
inflammatory lesion count (papules, pustules, and nodules) and non-inflammatory lesion count (open and closed comedones)
Interventions
- BIOLOGICAL Vehicle
- BIOLOGICAL ANT-1207
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-07 |
| Phase | Phase 2 |
What the finished NCT01293552 record still lists
NCT01293552 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (46% lower).
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT01293552 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01293552 about?
NCT01293552 is a clinical study titled "Clinical Trial To Evaluate ANT-1207 In Subjects With Acne". The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of ANT-1207 in the treatment of acne.
What is the current status of trial NCT01293552?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 72 participants. The study started on 2011-01. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01293552?
The interventions under investigation include: Vehicle (BIOLOGICAL), ANT-1207 (BIOLOGICAL).
Who is sponsoring clinical trial NCT01293552?
This trial is sponsored by Anterios, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01293552's enrollment target sits among peer trials
72 925th of 2000 higher than 1,065 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia